Literature DB >> 18584165

Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid.

R Cordoba, E Ramirez, S H Lei, A Lopez de la Guia, M J Sanjurjo, A J Carcas, F Hernandez-Navarro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18584165     DOI： 10.1007/s00228-008-0517-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  9 in total

1.  Hypercalcemia due to all-trans retinoic acid therapy for acute promyelocytic leukemia: a case report of effective treatment with bisphosphonate.

Authors:  O Sakamoto; M Yoshinari; T Rikiishi; I Fujiwara; M Imaizumi; S Tsuchiya; K Iinuma
Journal:  Pediatr Int       Date:  2001-12       Impact factor: 1.524

2.  Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes.

Authors:  Toshiro Niwa; Toshifumi Shiraga; Akira Takagi
Journal:  Biol Pharm Bull       Date:  2005-09       Impact factor: 2.233

3.  All-trans retinoic acid induced hypercalcemia in a patient with acute promyelocytic leukemia: its relation to increased PTH-rP.

Authors:  M Nagasawa; H Okawa
Journal:  Int J Hematol       Date:  1994-02       Impact factor: 2.490

4.  Hypercalcemia due to all trans retinoic acid in the treatment of acute promyelocytic leukemia potentiated by voriconazole.

Authors:  Matthew T Bennett; Sandra Sirrs; Janice K Yeung; Clayton A Smith
Journal:  Leuk Lymphoma       Date:  2005-12

5.  Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.

Authors:  N A Rizvi; J L Marshall; E Ness; J Yoe; G M Gill; J A Truglia; G R Loewen; D Jaunakais; E H Ulm; M J Hawkins
Journal:  Clin Cancer Res       Date:  1998-06       Impact factor: 12.531

6.  Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.

Authors:  Miguel A Sanz; Guillermo Martín; Marcos González; Angel León; Chelo Rayón; Concha Rivas; Dolors Colomer; Elena Amutio; Francisco J Capote; Gustavo A Milone; Javier De La Serna; José Román; Eva Barragán; Juan Bergua; Lourdes Escoda; Ricardo Parody; Silvia Negri; María J Calasanz; Pascual Bolufer
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

7.  Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.

Authors:  M A Smith; P C Adamson; F M Balis; J Feusner; L Aronson; R F Murphy; M E Horowitz; G Reaman; G D Hammond; R M Fenton
Journal:  J Clin Oncol       Date:  1992-11       Impact factor: 44.544

8.  Hypercalcaemia and increased serum interleukin-6 levels induced by all-trans retinoic acid in patients with multiple myeloma.

Authors:  R Niesvizky; D S Siegel; X Busquets; G Nichols; J Muindi; R P Warrell; J Michaeli
Journal:  Br J Haematol       Date:  1995-01       Impact factor: 6.998

9.  Hypercalcemia associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.

Authors:  M Sakakibara; M Ichikawa; Y Amano; S Matsuzawa; K Agematsu; T Mori; K Koike; T Nakahata; A Komiyama
Journal:  Leuk Res       Date:  1993-05       Impact factor: 3.156
  9 in total
  7 in total

1.  All-trans-retinoic acid induced acute pancreatitis: a single or multifactorial association?

Authors:  Rodrigo Lopes da Silva
Journal:  Int J Hematol       Date:  2011-04-07       Impact factor: 2.490

2.  All-Trans-Retinoic-Acid Unmasking Hypercalcemia of Hyperparathyroidism.

Authors:  Uday Yanamandra; Kamal Kant Sahu; Alka Khadwal; Gaurav Prakash; Subhash Chander Varma; Pankaj Malhotra
Journal:  Indian J Hematol Blood Transfus       Date:  2015-09-08       Impact factor: 0.900

3.  Therapeutic effects of all trans-retinoic acid combined with transarterial chemoembolization on Walker-256 hepatoma in rats.

Authors:  Jianlin Fang; Chuansheng Zheng; Hongfang Tao; Hui Zhao; Jianzhuang Ren; Gansheng Feng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

Review 4.  Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics.

Authors:  Cara H Nelson; Brian R Buttrick; Nina Isoherranen
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

5.  Zoledronic acid inhibits the growth of leukemic MLL-AF9 transformed hematopoietic cells.

Authors:  Emanuela Chiarella; Bruna Codispoti; Annamaria Aloisio; Emanuela G Cosentino; Stefania Scicchitano; Ylenia Montalcini; Daniela Lico; Giovanni Morrone; Maria Mesuraca; Heather M Bond
Journal:  Heliyon       Date:  2020-06-05

Review 6.  The safety of isotretinoin treatment in patients with bone fractures.

Authors:  Bartosz Miziołek; Beata Bergler-Czop; Anna Stańkowska; Ligia Brzezińska-Wcisło
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837

7.  Hypercalcemia and acute pancreatitis in a male patient with acute promyelocytic leukemia and pulmonary tuberculosis.

Authors:  Ali S Abdullah; Ahmad M Adel; Radwa M Hussein; Mohammed Aj Abdullah; Anil Yousaf; Deena Mudawi; Shehab F Mohamed; Abdulqadir J Nashwan; Dina Soliman; Feryal Ibrahim; Mohamed A Yassin
Journal:  Acta Biomed       Date:  2018-04-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.